Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Wodak

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
The International Journal on Drug Policy|September 4, 2007
The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settingsMofizul Islam, Alex Wodak, Katherine M Conigrave
Harm Reduction Journal|May 23, 2008
Harm reduction and equity of access to care for French prisoners: a reviewLaurent Michel, M Patrizia Carrieri, Alex Wodak
BMJ (Clinical Research Ed.)|February 15, 2014
New Zealand's regulation of new psychoactive substancesJack Newberry, Alex Wodak, Doug Sellman, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 12, 2005
Methadone vs buprenorphineAndrew Byrne, Richard Hallinan, Richard Watson, et al.
Drug and Alcohol Review|July 21, 2022
A critical analysis of 'Electronic cigarettes and health outcomes: Systematic review of global evidence'Colin Paul Mendelsohn, Alex Wodak, Wayne Hall, et al.
Drug and Alcohol Review|November 24, 2007
Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot studyMofizul Islam, Tim Stern, Katherine M Conigrave, et al.
Drug and Alcohol Review|August 22, 2002
Substitution therapy for amphetamine usersJames Shearer, John Sherman, Alex Wodak, et al.
Drug and Alcohol Review|May 7, 2011
Increasing the benefits and reducing the harms of prescription opioid analgesicsRichard Hallinan, Mary Osborn, Milton Cohen, et al.
AIDS (London, England)|July 25, 2008
Refocusing and prioritizing HIV programmes in conflict and post-conflict settings: funding recommendationsBrent W Hanson, Alex Wodak, Agnès Fiamma, et al.
BMJ (Clinical Research Ed.)|January 12, 2002
Cannabis control: costs outweigh the benefits. ForAlex Wodak, Craig Reinarman, Peter D A Cohen, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
The International Journal on Drug Policy|September 4, 2007
The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settingsMofizul Islam, Alex Wodak, Katherine M Conigrave
Harm Reduction Journal|May 23, 2008
Harm reduction and equity of access to care for French prisoners: a reviewLaurent Michel, M Patrizia Carrieri, Alex Wodak
BMJ (Clinical Research Ed.)|February 15, 2014
New Zealand's regulation of new psychoactive substancesJack Newberry, Alex Wodak, Doug Sellman, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 12, 2005
Methadone vs buprenorphineAndrew Byrne, Richard Hallinan, Richard Watson, et al.
Drug and Alcohol Review|July 21, 2022
A critical analysis of 'Electronic cigarettes and health outcomes: Systematic review of global evidence'Colin Paul Mendelsohn, Alex Wodak, Wayne Hall, et al.
Drug and Alcohol Review|November 24, 2007
Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot studyMofizul Islam, Tim Stern, Katherine M Conigrave, et al.
Drug and Alcohol Review|August 22, 2002
Substitution therapy for amphetamine usersJames Shearer, John Sherman, Alex Wodak, et al.
Drug and Alcohol Review|May 7, 2011
Increasing the benefits and reducing the harms of prescription opioid analgesicsRichard Hallinan, Mary Osborn, Milton Cohen, et al.
AIDS (London, England)|July 25, 2008
Refocusing and prioritizing HIV programmes in conflict and post-conflict settings: funding recommendationsBrent W Hanson, Alex Wodak, Agnès Fiamma, et al.
BMJ (Clinical Research Ed.)|January 12, 2002
Cannabis control: costs outweigh the benefits. ForAlex Wodak, Craig Reinarman, Peter D A Cohen, et al.
Pageof 8